Symbol: |
ZNF512B
|
Description: |
zinc finger protein 512B [Source:HGNC Symbol;Acc:29212]
|
Location: |
Chr20:62588055-62680113[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:223
Gene |
Compound |
Gen_sig |
Exp_pattern |
ZNF512B |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.004 |
Down |
ZNF512B |
ANTINEOPLASTIC-376265 |
0.036 |
Down |
ZNF512B |
PHYTOENE |
0.007 |
Down |
ZNF512B |
1,2-Naphthoquinone, 3,7-dimethyl- |
0.013 |
Down |
ZNF512B |
NSC 49789 |
0.022 |
Down |
ZNF512B |
NSC 527353 |
0.039 |
Up |
ZNF512B |
NSC 57958 |
0.035 |
Down |
ZNF512B |
NSC 58903 |
0.012 |
Down |
ZNF512B |
Camptothecin ethylglycinate ester hydrochloride |
0.047 |
Down |
ZNF512B |
RAPAMYCIN PRODRUG |
0.004 |
Down |
ZNF512B |
Camptothecin hemisuccinate sodium salt |
0.049 |
Down |
ZNF512B |
Camptothecin lysinate HCl |
0.012 |
Down |
ZNF512B |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.045 |
Down |
ZNF512B |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.01 |
Down |
ZNF512B |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.025 |
Down |
Expression pattern: Sensitivity / Resistance
Total:15 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:36
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:4
Gene |
Gen_transcript |
miRNA |
miR_location |
ZNF512B |
ENST00000217130 |
hsa-mir-519a-5p |
Chr19:54255665-54255686[+] |
ZNF512B |
ENST00000217130 |
hsa-mir-548d-3p |
Chr17:65467620-65467641[-] |
ZNF512B |
ENST00000217130 |
hsa-mir-548d-3p |
Chr8:124360289-124360310[-] |
ZNF512B |
ENST00000217130 |
hsa-mir-892b |
ChrX:145078726-145078747[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|